Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Angioedema with sacubitril/valsartan: Trial-level meta-analysis of over 14,000 patients and real-world evidence to date

International Journal of Cardiology(2020)10.1016/j.ijcard.2020.08.067Source: DataRank Database

Angioedema with sacubitril/valsartan: Trial-level meta-analysis of over 14,000 patients and real-world evidence to date is a research paper published in International Journal of Cardiology (2020). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

14 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.66)OA: closedTopics (27)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Sarju Ganatra ORCID,Muthiah Vaduganathan ORCID,Sourbha S. Dani ORCID

Live enrichment

PubMed:32841619 OpenAlex:https://openalex.org/W3080744672

Boehringer Ingelheim

National Institutes of Health

Cytokinetics

FWCI

0.66

Citation Percentile

0.6%

Citation Trend

2021

2022

2023

2024

2025

2026

closedLicense: https://www.elsevier.com/legal/tdmrep-license

publisherhttps://api.elsevier.com/content/article/PII:S0167527320336500?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0167527320336500?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ijcard.2020.08.067

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32841619

Fields of Study

Coagulation, Bradykinin, Polyphosphates, and AngioedemaPotassium and Related DisordersHeart Failure Treatment and Management

MeSH Terms

ValsartanAminobutyratesAngioedemaBiphenyl CompoundsDrug CombinationsHeart FailureHumansStroke VolumeTetrazolesAngiotensin Receptor Antagonists

Keywords

MedicineAngioedemaValsartanSacubitril, ValsartanPharmacovigilanceSacubitrilAdverse effectInternal medicineClinical trialRandomized controlled trialBlood pressureFda Adverse Event Reporting SystemSacubitril/valsartanReal-world Pharmacovigilance

Sustainable Development Goals

SDG 0: Good health and well-being

Angioedema with sacubitril/valsartan: Trial-level meta-analysis of over 14,000 patients and real-world evidence to date

FAIR Checklist

Authors (3)

Funding (3 grants)

Impact

Open Access

Topics